SL Science Holding Limited (SLBT)
NASDAQ: SLBT · Real-Time Price · USD
2.660
-0.050 (-1.85%)
Aug 14, 2026, 4:00 PM EDT - Market closed
SL Science Holding Revenue
SL Science Holding had revenue of $564.62K in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $3.27M. In the year 2024, SL Science Holding had annual revenue of $3.36M with 282.68% growth.
Revenue (ttm)
$3.27M
Revenue Growth
+282.68%
P/S Ratio
131.47
Revenue / Employee
$218,007
Employees
15
Market Cap
429.92M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.36M | 2.48M | 282.68% |
| Dec 31, 2023 | 878.97K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
SLBT News
- 3 days ago - SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma - GlobeNewsWire
- 4 weeks ago - SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology - GlobeNewsWire
- 5 weeks ago - SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma - GlobeNewsWire
- 2 months ago - Why Is SL Science Stock (SLBT) Up Today? - TipRanks
- 2 months ago - SL BIO Ltd. and Horizon Space Acquisition II Announce Closing of Business Combination and Listing on the Nasdaq Global Market - GlobeNewsWire